tiprankstipranks
Propanc Biopharma (PPCB)
NASDAQ:PPCB
US Market
PPCB
Propanc Biopharma
RESEARCH TOOLSreports
Want to see PPCB full AI Analyst Report?

Propanc Biopharma (PPCB) Ratios

70 Followers

Propanc Biopharma Ratios

PPCB's free cash flow for Q3 2026 was $0.00. For the 2026 fiscal year, PPCB's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 2.37 1.50 <0.01 <0.01 <0.01
Quick Ratio
 2.37 1.50 <0.01 <0.01 <0.01
Cash Ratio
 0.13 <0.01 <0.01 <0.01 <0.01
Solvency Ratio
 -4.07 -10.29 -0.47 -0.83 -0.86
Operating Cash Flow Ratio
 -1.18 -0.07 -0.25 -0.35 -0.47
Short-Term Operating Cash Flow Coverage
 -7.57 -0.26 -1.07 -2.19 -1.47
Net Current Asset Value
$ 3.72M$ 2.63M$ -3.83M$ -3.16M$ -3.09M
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.09 13.10 9.05 12.74
Debt-to-Equity Ratio
 0.16 0.12 -0.25 -0.18 -0.34
Debt-to-Capital Ratio
 0.14 0.11 -0.33 -0.21 -0.52
Long-Term Debt-to-Capital Ratio
 0.09 <0.01 -0.02 0.00 0.00
Financial Leverage Ratio
 1.46 1.41 -0.02 -0.02 -0.03
Debt Service Coverage Ratio
 -14.72 -27.45 -0.74 -2.03 -1.35
Interest Coverage Ratio
 -27.95 -101.60 -2.31 -3.34 -3.50
Debt to Market Cap
 1.22 0.10 8.40 0.62 44.04K
Interest Debt Per Share
 2.49 14.43 1.14K 10.79K 536.44K
Net Debt to EBITDA
 -0.06 -0.03 -0.73 -0.24 -0.48
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%93.38%95.38%97.97%
EBT Per EBIT
99.93%102.87%126.95%157.01%136.26%
Return on Assets (ROA)
-128.10%-300.14%-2516.41%-4410.89%-3255.32%
Return on Equity (ROE)
-151.28%-423.72%48.19%85.37%87.91%
Return on Capital Employed (ROCE)
-169.22%-407.57%41.29%57.36%66.78%
Return on Invested Capital (ROIC)
-161.15%-366.39%50.67%65.89%98.36%
Return on Tangible Assets
-128.10%-300.14%-2516.41%-4410.89%-3255.32%
Earnings Yield
-1124.56%-357.81%-1647.58%-328.52%-11972972.97%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 0.02 0.02 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -53.96K 0.00 -20.45K -19.87K 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 53.96K 0.00 20.45K 19.87K 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -4.58 -2.55 -659.93 -11.05K -478.77K
Free Cash Flow Per Share
 -4.58 -2.55 -659.93 -11.05K -478.77K
CapEx Per Share
 <0.01 0.00 <0.01 0.01 1.33
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -1.31M 0.00 -467.56K -1.11M -359.08K
Capital Expenditure Coverage Ratio
 -1.31M 0.00 -467.56K -1.11M -359.08K
Operating Cash Flow Coverage Ratio
 -2.61 -0.23 -0.99 -2.02 -1.38
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-258.47%-2.46%-846.06%-136.45%-6469837.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.07 -0.28 -0.06 -0.30 >-0.01
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 0.13 1.18 -0.03 -0.26 >-0.01
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.31 -40.64 -0.12 -0.73 >-0.01
Price-to-Operating Cash Flow Ratio
 -0.32 -40.64 -0.12 -0.73 >-0.01
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 <0.01 <0.01 >-0.01
Price-to-Fair Value
 0.13 1.18 -0.03 -0.26 >-0.01
Enterprise Value Multiple
 -0.14 -0.31 -0.82 -0.60 -0.48
Enterprise Value
 2.72M 18.18M 1.04M 1.35M 1.04M
EV to EBITDA
 -0.15 -0.31 -0.82 -0.60 -0.48
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -0.66 -44.88 -1.11 -1.22 -0.72
EV to Operating Cash Flow
 -0.66 -44.88 -1.11 -1.22 -0.72
Tangible Book Value Per Share
 10.96 87.61 -2.67K -31.17K -1.01M
Shareholders’ Equity Per Share
 10.96 87.61 -2.67K -31.17K -1.01M
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.07 0.05 0.02
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -20.47 -371.22 -1.29K -26.61K -886.00K
Tax Burden
 1.00 1.00 0.93 0.95 0.98
Interest Burden
 1.03 1.01 1.52 1.24 1.27
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.22 <0.01 0.51 0.42 0.54
Currency in USD